EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Postoperative Probiotics Administration Attenuates Gastrointestinal Complications and Gut Microbiota Dysbiosis Caused by Chemotherapy in Colorectal Cancer Patients

Feng Huang iD, Shengjie Li iD, Wenjie Chen iD, Yiyang Han, Yue Yao, Liang Yang, Qiang Li, Qun Xiao, Jing Wei, Zhaoxia Liu, Tingtao Chen iD, Xiaorong Deng

Nutrients · 11.01.2023 · 15 (2) · 356

DOI: 10.3390/nu15020356 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 11.01.2023. Verfasst von Feng Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Microbiome, Probiotics. Die Arbeit wurde bisher 165-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi province, Health Commission Foundation of Jiangxi province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current study aims to evaluate the potential roles of taking probiotics postoperatively in attenuating the gastrointestinal complications and disturbed gut microbiota in colorectal cancer (CRC) patients undergoing chemotherapy. One hundred eligible CRC patients who were treated with radical surgery and needed to receive chemotherapy were recruited. Half of them were randomly assigned to the Probio group to take a probiotic combination from post-operation to the end of the first chemotherapeutic course. The other half of patients taking placebo instead were classified as the Placebo group. Gastrointestinal complications such as nausea, acid reflux, abdominal pain, abdominal distention, constipation, and diarrhea were recorded during chemotherapy. Fecal samples were collected preoperatively and after the first cycle of postoperative chemotherapy for 16S rRNA high-throughput sequencing and short-chain fatty acids (SCFAs) analysis. Results showed that probiotics administration could effectively reduce chemotherapy-induced gastrointestinal complications, particularly in diarrhea (p < 0.01). Additionally, chemotherapy also reduced the bacterial diversity indexes of the gut microbiota in CRC patients, which could be significantly increased by taking probiotics. Moreover, this chemotherapy caused significant changes in the composition of the gut microbiota, as indicated by decreased phylum levels of Firmicutes and increased Bacteroidetes, Proteobacteria, and Verrucomicrobia. In particular, several bacterial genera such as Akkermansia and Clostridium were significantly increased, while Prevotella, Lactobacillus, and Roseburia were decreased (p < 0.05). However, probiotic administration could effectively restore these taxa changes both at the phylum and genus levels, and mildly increase the genus levels of Bifidobacterium, Streptococcus, and Blautia. Furthermore, probiotics could also promote the production of SCFAs, particularly increasing acetate, butyrate, and propionate (p < 0.0001). These results support the beneficial effects of the probiotic interventions as novel alternative or complementary strategies in chemoprevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGastrointestinal DiseasesGastrointestinal MicrobiomeProbioticsHumansBacteriaDiarrheaDysbiosisFatty Acids, VolatileRNA, Ribosomal, 16S

Stichwörter der Autor:innen

CRCchemotherapygastrointestinal complicationsgut microbiotaprobiotics

Substanzen

Fatty Acids, VolatileRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Institute of Translational Medicine, Nanchang University, Nanchang 330031, China.
  • Department of Vascular Surgery, Tengzhou Central People's Hospital, Zaozhuang 277599, China.
  • Department of Hepatobiliary Pancreatic Splenic Surgery, The First Affiliated Hospital of Hunan College of Traditional Chinese Medicine, Zhuzhou 410208, China.
  • Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.

ORCID-Profile: Feng Huang, Shengjie Li, Wenjie Chen, Tingtao Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangxi province
  • Health Commission Foundation of Jiangxi province
  • Double thousand plan of Jiangxi Province

Zitieren

APA

Huang, F., Li, S., Chen, W., Han, Y., Yao, Y., Yang, L., Li, Q., Xiao, Q., Wei, J., Liu, Z., Chen, T., & Deng, X. (2023). Postoperative Probiotics Administration Attenuates Gastrointestinal Complications and Gut Microbiota Dysbiosis Caused by Chemotherapy in Colorectal Cancer Patients. Nutrients, 15(2), 356. https://doi.org/10.3390/nu15020356

Vancouver

Huang F, Li S, Chen W, Han Y, Yao Y, Yang L, et al. Postoperative Probiotics Administration Attenuates Gastrointestinal Complications and Gut Microbiota Dysbiosis Caused by Chemotherapy in Colorectal Cancer Patients. Nutrients. 2023;15(2):356. doi:10.3390/nu15020356

BibTeX
@article{Huang2023,
  author = {Huang, Feng and Li, Shengjie and Chen, Wenjie and Han, Yiyang and Yao, Yue and Yang, Liang and Li, Qiang and Xiao, Qun and Wei, Jing and Liu, Zhaoxia and Chen, Tingtao and Deng, Xiaorong},
  title = {Postoperative Probiotics Administration Attenuates Gastrointestinal Complications and Gut Microbiota Dysbiosis Caused by Chemotherapy in Colorectal Cancer Patients},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {356},
  doi = {10.3390/nu15020356}
}
Kostenlos starten →